BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24332487)

  • 1. Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors.
    He Y; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Ruiz CH; Lograsso PV; Kamenecka TM; Koenig M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):161-4. PubMed ID: 24332487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.
    Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.
    He Y; Kamenecka TM; Shin Y; Song X; Jiang R; Noel R; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Khan S; Koenig M; LoGrasso PV
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1719-23. PubMed ID: 21316221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
    Humphries PS; Lafontaine JA; Agree CS; Alexander D; Chen P; Do QQ; Li LY; Lunney EA; Rajapakse RJ; Siegel K; Timofeevski SL; Wang T; Wilhite DM
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2099-102. PubMed ID: 19327989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.
    Noël R; Shin Y; Song X; He Y; Koenig M; Chen W; Ling YY; Lin L; Ruiz CH; LoGrasso P; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2011 May; 21(9):2732-5. PubMed ID: 21185177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors.
    Shin Y; Chen W; Habel J; Duckett D; Ling YY; Koenig M; He Y; Vojkovsky T; LoGrasso P; Kamenecka TM
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3344-7. PubMed ID: 19433357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.
    Jiang R; Frackowiak B; Shin Y; Song X; Chen W; Lin L; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2013 May; 23(9):2683-7. PubMed ID: 23518277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors.
    De SK; Chen LH; Stebbins JL; Machleidt T; Riel-Mehan M; Dahl R; Chen V; Yuan H; Barile E; Emdadi A; Murphy R; Pellecchia M
    Bioorg Med Chem; 2009 Apr; 17(7):2712-7. PubMed ID: 19282190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
    Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.
    Kamenecka T; Jiang R; Song X; Duckett D; Chen W; Ling YY; Habel J; Laughlin JD; Chambers J; Figuera-Losada M; Cameron MD; Lin L; Ruiz CH; LoGrasso PV
    J Med Chem; 2010 Jan; 53(1):419-31. PubMed ID: 19947601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
    Schepetkin IA; Khlebnikov AI; Potapov AS; Kovrizhina AR; Matveevskaya VV; Belyanin ML; Atochin DN; Zanoza SO; Gaidarzhy NM; Lyakhov SA; Kirpotina LN; Quinn MT
    Eur J Med Chem; 2019 Jan; 161():179-191. PubMed ID: 30347329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors.
    De SK; Chen V; Stebbins JL; Chen LH; Cellitti JF; Machleidt T; Barile E; Riel-Mehan M; Dahl R; Yang L; Emdadi A; Murphy R; Pellecchia M
    Bioorg Med Chem; 2010 Jan; 18(2):590-6. PubMed ID: 20045647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the c-Jun N-Terminal Kinase Inhibitor
    Nagy MA; Hilgraf R; Mortensen DS; Elsner J; Norris S; Tikhe J; Yoon W; Paisner D; Delgado M; Erdman P; Haelewyn J; Khambatta G; Xu L; Romanow WJ; Condroski K; Bahmanyar S; McCarrick M; Benish B; Blease K; LeBrun L; Moghaddam MF; Apuy J; Canan SS; Bennett BL; Satoh Y
    J Med Chem; 2021 Dec; 64(24):18193-18208. PubMed ID: 34894681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
    Doma A; Kulkarni R; Palakodety R; Sastry GN; Sridhara J; Garlapati A
    Bioorg Med Chem; 2014 Nov; 22(21):6209-19. PubMed ID: 25261929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.
    Hom RK; Bowers S; Sealy JM; Truong AP; Probst GD; Neitzel ML; Neitz RJ; Fang L; Brogley L; Wu J; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Quinn K; Sauer JM; Powell K; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7303-7. PubMed ID: 21071223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.
    Liu M; Xin Z; Clampit JE; Wang S; Gum RJ; Haasch DL; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
    Bioorg Med Chem Lett; 2006 May; 16(10):2590-4. PubMed ID: 16527482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure-based optimization of 3-substituted indolin-2-one derivatives as potent and isoform-selective c-Jun N-terminal kinase 3 (JNK3) inhibitors and biological evaluation.
    Li Z; Zhu G; Liu X; Gao T; Fang F; Dou X; Li Y; Zheng R; Jin H; Zhang L; Liu Z; Zhang L
    Eur J Med Chem; 2023 Mar; 250():115167. PubMed ID: 36764123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel series of 4-quinolone JNK inhibitors.
    Gong L; Tan YC; Boice G; Abbot S; McCaleb K; Iyer P; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Lukacs CM; Ursula Kammlott R; Kuglstatter A; Goldstein D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7381-7. PubMed ID: 23142618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
    Gehringer M; Muth F; Koch P; Laufer SA
    Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.
    De SK; Barile E; Chen V; Stebbins JL; Cellitti JF; Machleidt T; Carlson CB; Yang L; Dahl R; Pellecchia M
    Bioorg Med Chem; 2011 Apr; 19(8):2582-8. PubMed ID: 21458276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.